Search by Drug Name or NDC

    NDC 82009-0001-10 ATORVASTATIN CALCIUM 10 mg/1 Details

    ATORVASTATIN CALCIUM 10 mg/1

    ATORVASTATIN CALCIUM is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Quallent. The primary component is ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE.

    Product Information

    NDC 82009-0001
    Product ID 82009-001_d0513f11-a7bd-87b3-cd04-ace3f7a69579
    Associated GPIs 39400010100310
    GCN Sequence Number 029967
    GCN Sequence Number Description atorvastatin calcium TABLET 10 MG ORAL
    HIC3 M4D
    HIC3 Description ANTIHYPERLIPIDEMIC-HMGCOA REDUCTASE INHIB(STATINS)
    GCN 43720
    HICL Sequence Number 012404
    HICL Sequence Number Description ATORVASTATIN CALCIUM
    Brand/Generic Generic
    Proprietary Name ATORVASTATIN CALCIUM
    Proprietary Name Suffix n/a
    Non-Proprietary Name ATORVASTATIN CALCIUM
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 10
    Active Ingredient Units mg/1
    Substance Name ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE
    Labeler Name Quallent
    Pharmaceutical Class HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA090548
    Listing Certified Through 2024-12-31

    Package

    NDC 82009-0001-10 (82009000110)

    NDC Package Code 82009-001-10
    Billing NDC 82009000110
    Package 1000 TABLET, FILM COATED in 1 BOTTLE (82009-001-10)
    Marketing Start Date 2021-11-23
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.03013
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description ATORVASTATIN 10 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis